Q1 2025 Marchex Inc Earnings Call
Edwin Miller; Chief Executive Officer; Marchex Inc
Brian Nagle; Principal Financial Officer and Principal Accounting Officer; Marchex Inc
Operator
Good afternoon and thank you for joining today's first-quarter 2025 Marchex earnings conference call. (Operator Instructions)I now hand the call over to Trevor Caldwell, Senior Vice President of Investment Relations and Strategic Initiatives. You may proceed.
Trevor Caldwell
Thank you, Joel. Good afternoon, everyone, and welcome to Marchex's business update and first-quarter 2025 conference call. Joining us today are Edgar Miller, our CEO; Russ Horowitz, our Chairman of the Board; and Brian Nagel, our SVP, Corporate Controller.Before we get started, I would like to take this opportunity to remind you that our remarks today will include forward-looking statements, including references to our financial and operational performance, and actual results may differ materially from those contemplated by these forward-looking statements. Risks and uncertainties that could cause these results to differ materially are set forth in today's earnings press release and in our most recent annual and quarterly report filed with the SEC. Any forward-looking statements that we make on this call are based on assumptions as of today, and we undertake no obligation to update these statements for subsequent events.During this call, we will present both GAAP and non-GAAP financial measures. A reconciliation of GAAP to non-GAAP measures is included in today's earnings press release. The earnings press release is available on the Investor Relations section of our website.At this time, I'd like to turn the call over to Edwin.
Edwin Miller
Thank you, Trevor. Good afternoon, everyone, and thank you for joining us today. We are excited to mark the successful combination of key milestones in Marchex's two-year strategic, financial, and operational transformation. Over this period, Marchex has evolved into a SaaS-based prescriptive analytics provider powered by AI and proprietary first-party conversational data. This evolution has redefined who we are from our core technology platform to our product suite and how we serve our customers.Let's begin with our new technology foundation. With our OneStack platform unification initiative, we have consolidated the company's technology stack and data architecture into a single cloud-based architecture. This foundational project centralizes Marchex's large repository of first-party conversational data and powers the application of generative AI across the platform. This architecture now serves as the backbone for all future innovation and is already delivering impact across our business and for our customers. Because of this transformation, we have strengthened our financial profile meaningfully.We are already seeing benefits. Our gross margin has increased by approximately 8% compared to the first quarter of 2023. OneStack allows us to operate with a more efficient cost structure, giving us the ability as we go forward to drop significant additional leverage to the bottom line as our product and customer momentum increases. We feel Marchex is incredibly well positioned to expand and drive incremental profitability as we introduce new AI products and features and drive more revenue. We believe that we are now at a strategic inflection point in our business.With a new, more scalable, and profitable technology foundation, we are transitioning our focus to acceleration across our business. This will involve capitalizing on current momentum through launching innovative AI solutions, expanding sales channels, and deepening our presence in high-value verticals. We are strategically very well positioned in our four core verticals, which are auto, auto services, home services, and healthcare as well as other select industries. Additionally, we have now expanded our product capabilities to support all four business functions for our existing and new customers, including sales, marketing, service, and operations. In terms of progress, I want to highlight just a few examples.First, we announced an expanded relationship with one of the largest Fortune 500 auto OEMs to include access to their base of more than 3,000 franchised auto dealerships to sell our flagship Engage for Sales product and our new Engage for Service product. This represents a new multimillion dollar opportunity for Marchex. We announced our new Engage for Service product just over a month ago, which enables Marchex to deliver AI-driven insights on service calls, which helps auto service departments recover missed opportunities, boost revenue, and increase lifetime customer value. This new AI-powered conversational intelligence solution is designed to help service centers better understand their customer engagement, elevates customer satisfaction, recover lost opportunities and increase revenue. Auto service centers are the backbone of dealerships, handling approximately 50% of all inbound calls.Marchex now has a deferred or exclusive access to approximately 9,000 auto franchise dealerships with our current relationships. With our Engage offering now including both sales and service, we are opening incremental opportunity for Marchex to meaningfully expand our footprint and potential sell-through to a very large vertical market over time. Second, I'm excited to talk about the launch of our new user interface. This month, we launched our first ever comprehensive unified interface for customers across our products, which is an integrated element of the OneStack cloud technology platform. This initiative will lead to a unified customer experience and create more seamless upsell opportunities with new click to buy functionality.With the new UI, we can deliver broadly applicable new AI features such as industry and customized benchmarking to our customers. Third, I'm excited to share that we have launched our first product into the Microsoft marketplace, marking an important step in expanding our go-to market strategy from one to one to one to many. As previously announced, Marchex entered to a strategic collaboration with Microsoft through the Microsoft Cloud AI Partner Program. This partnership makes Marchex's AI-powered conversational analytics solution globally accessible via Azure, providing a powerful channel to reach a broader enterprise audience. By leveraging a combination of direct enterprise sales, OEM relationships, technology integrators and platforms like Azure, Marchex is scaling our solutions more efficiently and solidifying our position as a trusted provider of conversational intelligence for large organizations.In the coming months, we expect to introduce additional products across other leading marketplaces as well as with key integration and channel partners. Over time, we expect the combination of new AI-powered vertical signals and channel partnerships will be an important driver for growth. These initiatives are the first of many executed so far in 2025. There is much more to come as highlighted in today's release. Our business' ability to execute innovation across our product platform, expand and add new customer relationships, and open new markets is just beginning.With that, I will hand the call to Brian to briefly overview some of our financial results and our guidance for 2025.
Brian Nagle
Thank you, Edwin.Revenue for the first quarter of 2025 was $11.4 million. As communicated in today's press release, first-quarter revenue was affected by some seasonal call traffic factors and the timing of when we began to benefit from certain new sales, which we believe on a run rate basis will still accrue to the benefit of our overall 2025 financial plan.For operating expenditures, we continue to see efficiencies throughout the business as we benefited from the realignment of the organization following the completion of OneStack. We anticipate that our gross profit margins in particular should improve as we are carrying an overall lower cost cost structure going forward, which could enable significant future operating leverage for the business as new products and features sell through. On the balance sheet, we expect the second quarter to see cash balances stable to up relative to the first-quarter amounts.Moving to annualized guidance, our 2025 financial plan reflects the belief that during 2025, we can grow to achieve more than $12.5 million in quarterly revenue or an annualized revenue run rate of $50 million or better by the end of 2025. With our progress with a more efficient cost structure at these revenue levels, we believe we can achieve more than $1.5 million in quarterly adjusted EBITDA or an annualized run rate of $6 million or more in adjusted EBITDA.We do want to acknowledge there is currently some uncertainty due to the macroeconomic climate and lack of visibility. There are scenarios that could cause potential customers' impacts and increase the variability of actual financial performance. However, with the current momentum in the business, we believe that we are in a strong position to sell more through our expanding product platform and expanding customer relationships. As this progress materializes, we believe that we are in a position to realize greater overall profitability through our efficiency initiatives in the business as we move forward.I also want to note Marchex's adoption of a new share repurchase program and the sale of an unused domain as reported in today's release. If you can please see our press release for those details.With that, I will hand the call back over to Edwin.
Edwin Miller
Thank you, Brian. We believe that Marchex has reached a key strategic inflection point. We are actively executing on a long-term vision to scale Marchex into a $100 million annual revenue business in the years ahead. Reaching this milestone will require building on our current momentum by launching innovative AI-driven solutions, broadening our sales channels, and strengthening our position in high-value verticals and expanded business functions, all while continuing to leverage our significant base of first-party conversational data to drive innovative solutions for Fortune 500 businesses and more.We are highly focused on making 2025 a year of acceleration. With a strong foundation and a clear strategic vision in place, we are confident in our ability to drive sustainable growth, maintain financial discipline, and deliver meaningful value to both our customers and shareholders. I want to personally thank our team for their hard work and dedication to helping this business reach this important inflection point. I look forward to updating you in the coming periods.With that, I will hand the call back to the operator.
Operator
Thank you. We will now open the line for questions. (Operator Instructions)There are no questions in queue. I'll hand the call back over to the management team for concluding remarks.
Edwin Miller
Thank you. Thank you, everyone, for attending the call. We look forward to future dialogue with our shareholders.
Brian Nagle
Thank you, everyone.
Operator
That concludes today's conference call. Thank you for your participation. You may now disconnect your lines.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
2 hours ago
- Associated Press
Land Betterment Celebrates Kim Bryden's Service as Foundational Board Member
FISHERS, IN / ACCESS Newswire / August 18, 2025 / Land Betterment Corporation, an Indiana Benefit Corporation and Certified B Corporation, announces that Kim Bryden, a founding Independent Director of its board, will be stepping down from her position. Her departure comes as she expands her leadership across multiple initiatives focused on food entrepreneurship and local economic development. Kim was one of the first members of Land Betterment's Board of Directors, joining at the Company's inception in 2020. She brought a strong background in food systems and a strategic mindset focused on creating economically vibrant, locally rooted supply chains. As the Founder and CEO of Cureate, a mission-driven firm working to build an empowered and interconnected local supply chain, Kim has been a driving force behind a more resilient and community-based food economy. She has continued to push that mission forward by splitting her time between several Cureate-led initiatives, including her work in the Mid-Atlantic and across the Mid-South. 'Kim took a chance on us, and we are extremely grateful,' said Kirk Taylor, President of Land Betterment. 'She brought energy, vision and a deep understanding of what it takes to create lasting change. From spending time in Central Appalachia learning directly from local entrepreneurs to helping us think big about how regional economies can thrive, Kim has played an important role in shaping our approach. Kim remains a valued partner and friend to the Land Betterment team, and we look forward to seeing where her leadership and creativity take her next.' During her tenure on the board, Kim's guidance helped Land Betterment stay connected to the needs of small businesses and local food systems. Her entrepreneurial mindset and ability to bridge corporate, community, and institutional interests left a lasting mark on initiatives like Betterment Harvest and the Entrepreneur Zones, where inclusivity and innovation remain central. 'It has been an honor to serve on the Land Betterment board and contribute to such a thoughtful and purpose-driven organization,' said Bryden. 'I will continue to cheer on the team and support their work from afar. Land Betterment is creating something truly meaningful, and I look forward to watching its continued growth and impact.' Kim was recently profiled in the Northwest Arkansas Business Journal in a feature titled 'The Road to Resilience.' The article highlights her leadership in building more inclusive and locally rooted food systems through her work at Cureate. Her commitment to supporting small businesses and creating community-driven economic opportunities closely reflects the values she brought to her role at Land Betterment. You can read the full article here on page 12. To learn more about Cureate, visit About Land Betterment Corporation Land Betterment Corporation, an Indiana Benefit Corporation and Certified B Corporation, is an environmental solutions company focused on fostering a positive impact through up-cycling former coal mining and industrial sites to create sustainable community development and job creation. The Company utilizes a complete solution-based lifecycle program to restore and rehabilitate the environment and revitalize communities in need of change and opportunity. Land Betterment accomplishes this by identifying un-reclaimed, run-down and neglected coal mining sites, fixing the environment through reclamation and remediation, and then repurposing the land to support a sustainable business that serves the community. Land Betterment firmly believes that with real solutions it is possible for restoration of impacted areas to live side-by-side long term employment, while building sustainable and safe surroundings for communities and our planet. For more information visit or connect with us on our social platforms - Facebook, Instagram, LinkedIn. Contacts: Mark LaVerghetta 317.537.0492 ext. 0 Chief Governance Officer, Corporate Finance [email protected] Stephanie Conzelman 207.205.0790 Stakeholder Engagement Director [email protected] SOURCE: Land Betterment Corporation press release
Business Upturn
3 hours ago
- Business Upturn
DCX Systems Executive Director and CFO Diwakaraiah N J resigns
DCX Systems Limited today announced key changes in its top management. Diwakaraiah N J, Executive Director and Chief Financial Officer (CFO), has tendered his resignation, effective from the close of business hours on August 31, 2025. The Board of Directors has formally taken note of his resignation and will appoint a new CFO in due course, informing the stock exchanges accordingly. In a simultaneous development, the Board approved the appointment of Gopinath Vedaprakash (DIN: 11241863) as an Additional Whole-Time Director, effective September 1, 2025, subject to shareholder approval. Vedaprakash brings over 37 years of extensive experience across business development, manufacturing operations, and technical leadership in multinational and multicultural electronics industries catering to Defence, Aerospace, Space, Industrial, and Transportation sectors. Prior to joining DCX Systems, Vedaprakash held senior leadership roles at Tata Advanced Systems Limited, Bharat Electronics Limited, Seagate Technology International, and Centum Electronics. He has specialized expertise in Microelectronics, Electronics Systems, Subsystems, and Electronic Manufacturing Services (EMS) serving missiles, radars, satellites, launch vehicles, metro systems, and other high-technology segments. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Yahoo
5 hours ago
- Yahoo
Quoin Pharmaceuticals Appoints New Chief Financial Officer to Support Commercialization Strategy
ASHBURN, Va., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) ('Quoin' or the 'Company'), a late clinical stage specialty pharmaceutical company focused on rare and orphan diseases, today announced the appointment of its new Chief Financial Officer as the Company advances its lead product candidate, QRX003, through pivotal clinical studies and prepares for potential commercialization. Quoin has appointed Sally Lawlor, BCL, FCA, as its new Chief Financial Officer, effective immediately. Ms. Lawlor is an accomplished finance executive with over 20 years of experience in financial leadership roles in public and private companies as well as a Big Four accounting firm. In her most recent role at Sebela Pharmaceuticals, Ms. Lawlor managed financial reporting under U.S. GAAP and IFRS, oversaw global tax planning and compliance, as well as budgeting, forecasting, and external audits. Prior to Sebela, she served in senior tax leadership positions at Aptiv Plc and spent over a decade at KPMG advising multinational clients, primarily in the pharmaceutical and technology sectors. Ms. Lawlor is a Fellow of Chartered Accountants Ireland and a member of the Irish Taxation Institute. 'As we move closer to completing our QRX003 registrational trials in Netherton Syndrome and prepare for a potential NDA filing next year, we are aligning our leadership structure to support the next phase of Quoin's growth,' said Dr. Michael Myers, Chief Executive Officer of Quoin. 'We are thrilled to welcome Sally as Chief Financial Officer. She has extensive experience in commercial-stage finance, global tax strategy design and implementation, as well as multinational compliance, which we believe makes her exceptionally qualified to guide Quoin through our transition into a revenue-generating company. Sally adds invaluable expertise to our executive team at this pivotal time. I also want to thank Gordon Dunn for his dedicated contribution during his tenure as Quoin's CFO. We wish him all the best in his future endeavors.' Quoin is currently conducting two pivotal clinical studies for QRX003 in Netherton Syndrome across sites in the U.S., Europe and the Middle East, with full enrollment expected in early to mid-Q1 2026. The Company is also advancing development programs for Peeling Skin Syndrome and a novel topical rapamycin platform targeting a range of rare dermatologic diseases. About Quoin Pharmaceuticals Ltd. Quoin Pharmaceuticals Ltd. is a late clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities and care teams. Quoin's innovative pipeline comprises four products in development that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Scleroderma, microcystic lymphatic malformations, venous malformations, angiofibromas and others. For more information, visit: or LinkedIn for updates. Cautionary Note Regarding Forward Looking Statements The Company cautions that statements in this press release that are not a description of historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words referencing future events or circumstances such as 'expect,' 'intend,' 'plan,' 'anticipate,' 'believe,' and 'will,' among others. All statements that reflect the Company's expectations, assumptions, projections, beliefs, or opinions about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, statements relating to advancing QRX003 through pivotal clinical studies and preparing for potential commercialization, preparing for a potential NDA filing next year, aligning the Company's leadership structure to support the next phase of Quoin's growth, the expected contribution of Ms. Lawlor, transitioning Quoin into a revenue-generating company, attaining full enrollment in early to mid-Q1 2026 for two pivotal clinical studies for QRX003 in Netherton Syndrome across sites in the U.S., Europe and the Middle East, advancing development programs for Peeling Skin Syndrome and a novel topical rapamycin platform targeting a range of rare dermatologic diseases and Quoin's products in development collectively having the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Scleroderma, microcystic lymphatic malformations, venous malformations, angiofibromas and others. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon the Company's current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties including, but not limited to, the Company's ability to pursue its regulatory strategy; the Company's ability to obtain regulatory approvals for commercialization of product candidates or to comply with ongoing regulatory requirements; the Company's ability to complete clinical trials on time and achieve desired results and benefits as expected; Ms. Lawlor's ability to contribute to Quoin's growth: the Company's ability to transition into a revenue-generating company: and other factors discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 and in other filings the Company has made and may make with the SEC in the future. One should not place undue reliance on these forward-looking statements, which speak only as of the date on which they were made. The Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as may be required by law. For further information, contact: Quoin Pharmaceuticals Michael Myers, Ph.D., CEOmmyers@ Investor RelationsPCG AdvisoryJeff Ramsonjramson@ 863-6341
